M84.675S Pathological fracture in other disease, left foot, sequela

Name of the Condition

• Pathological Fracture in Other Disease, Left Foot, Sequela (ICD-10-CM: M84.675S)

Summary

This condition describes a pathological fracture in the left foot resulting from an underlying disease, with residual effects or complications persisting after the acute phase of healing. The fracture occurs due to weakened bone structure caused by conditions such as metabolic disorders, infections, or systemic diseases, leading to structural compromise. It is distinct from fractures caused by external injury and requires documentation of the underlying disease to support the diagnosis. This code specifically applies to the sequela (residual) stage of the fracture.

Causes

Pathological fractures in the left foot arise from diseases that impair bone integrity. Common underlying causes include metabolic bone disorders (e.g., osteomalacia), chronic infections (e.g., tuberculosis), or systemic diseases affecting bone density. These conditions reduce bone strength, making the left foot susceptible to fracture with minimal or no external force. The sequela stage reflects long-term effects of the fracture and underlying disease.

Risk Factors

• Advanced age, which increases bone fragility.
• Chronic diseases affecting bone metabolism (e.g., renal osteodystrophy, hyperparathyroidism).
• Prolonged use of medications that weaken bones (e.g., corticosteroids, anticonvulsants).
• Nutritional deficiencies, such as low calcium or vitamin D.
• History of bone disease or prior fractures.

Symptoms

• Persistent pain or discomfort at the fracture site.
• Limited mobility or stiffness in the left foot.
• Visible deformity or malalignment of the foot.
• Swelling or bruising that does not resolve.
• Difficulty bearing weight on the affected foot.

Diagnosis

Diagnosis involves a thorough clinical evaluation, including patient history of underlying diseases and fracture events. Imaging studies, such as X-rays, CT scans, or MRIs, are used to assess bone integrity and identify residual effects. Laboratory tests may be performed to evaluate underlying conditions contributing to bone weakness. Documentation of the sequela stage and its impact on function is essential for accurate coding.

Treatment Options

Treatment focuses on managing residual effects and preventing further complications. This may include pain management, physical therapy to improve mobility, orthotic devices for support, and addressing underlying diseases to stabilize bone health. Surgical intervention may be considered for severe deformities or persistent instability.

Prognosis and Follow-Up

Prognosis depends on the severity of the sequela and the effectiveness of managing the underlying disease. Regular follow-up is necessary to monitor bone health, functional status, and response to treatment. Long-term care may involve ongoing therapy and adjustments to address chronic symptoms or complications.

Complications

• Chronic pain or disability affecting daily activities.
• Progressive deformity or instability in the left foot.
• Increased risk of future fractures due to persistent bone weakness.
• Complications from underlying diseases (e.g., infection, metabolic imbalances).

Lifestyle & Prevention

• Maintain a balanced diet rich in calcium and vitamin D to support bone health.
• Engage in weight-bearing exercises to strengthen bones, as advised by a healthcare provider.
• Avoid high-impact activities that may exacerbate foot stress.
• Manage underlying conditions (e.g., diabetes, kidney disease) to reduce bone fragility.
• Use appropriate footwear and orthotics to provide support and reduce injury risk.

When to Seek Professional Help

Seek medical attention if you experience worsening pain, new swelling, difficulty walking, or signs of infection (e.g., redness, fever) at the fracture site. Prompt evaluation is important to address complications or adjust treatment plans.

Tips for Medical Coders

This code (M84.675S) is used for the sequela of a pathological fracture in the left foot due to an underlying disease. Documentation must specify the residual effects (e.g., chronic pain, deformity) and confirm the fracture is not acute or in the healing phase. Ensure the underlying disease is clearly documented to support the pathological fracture diagnosis. Use this code only when the sequela is the focus of the encounter.